DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
15.29
-0.40 (-2.55%)
Oct 10, 2025, 3:03 PM EDT - Market open
DarioHealth Revenue
DarioHealth had revenue of $5.37M in the quarter ending June 30, 2025, a decrease of -14.16%. This brings the company's revenue in the last twelve months to $27.15M, up 41.79% year-over-year. In the year 2024, DarioHealth had annual revenue of $27.04M with 32.86% growth.
Revenue (ttm)
$27.15M
Revenue Growth
+41.79%
P/S Ratio
1.57
Revenue / Employee
$134,396
Employees
202
Market Cap
86.98M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.04M | 6.69M | 32.86% |
Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
DRIO News
- 4 days ago - DarioHealth and OneStep Announce Strategic Collaboration to Integrate Smartphone-Only, Clinical-Grade Fall Risk Assessment Technology into Dario's Digital Health Multi-Condition Platform - PRNewsWire
- 15 days ago - DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest - PRNewsWire
- 18 days ago - DarioHealth Announces $17.5 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 5 weeks ago - DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market - PRNewsWire
- 5 weeks ago - Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025 - PRNewsWire
- 6 weeks ago - DarioHealth Announces 20-to-1 Reverse Stock Split - PRNewsWire
- 2 months ago - DarioHealth Corp. (DRIO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - DarioHealth Reports Second Quarter 2025 Financial and Operating Results - PRNewsWire